Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral vs Intravenous Cefuroxime for Pyelonephritis in Pregnancy
NCT06527560Phase 4Recruiting
- Sponsor
- Hospital de Clínicas de Porto Alegre
- Start
- Sep 2024
- Primary completion
- Dec 2027
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of cefuroxime axetil in pyelonephritis (2 arms), sponsored by Hospital de Clínicas de Porto Alegre. Primary endpoints: Clinical improvement at 3 days and Negative urine culture at 21 days. Started Sep 2024; status: recruiting.
02
Drugs
cefuroxime axetil
03
Conditions
pyelonephritis
Beyond the preview
Go deeper on NCT06527560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06527560.